What are the limits in the fight against obesity? Ozempic owner disappoints the market
Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema
An experimental vaccine increases survival rates by up to 50% in four people with highly-aggressive brain cancer
Spanish biochemist Héctor Méndez and his colleagues from the University of Florida have achieved ‘promising’ results in their initial human trial
Big Pharma’s dogfight to dominate the anti-obesity market
Around the world, 100 companies have debuted weight-loss medications, which have become a multimillion-dollar business. Novo Nordisk’s Ozempic is currently the best-known, but it’s far from the only option
Ten drugs targeted for Medicare price negotiations as Biden pitches cost reductions
The drugs include the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications
New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season
The Food and Drug Administration on Monday approved the injection for infants and children up to 2 years old. It’s made by AstraZeneca and is already approved in Canada and Europe